James Waisman
Medical Oncology · Duarte, CANPI 1356391270
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,961 of the $7,776 with a category attached, or 76.7%. 9 manufacturers reported payments, led by Taiho Oncology, Inc. at 54.8% of the total. 2023 is the largest year on record at $4,528, more than ten times the $210 reported in 2019.
Across 31 payments — averaging $250.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Taiho Oncology, Inc.$4K
- Novartis$3K
- Gilead$41
- AstraZeneca$36
- Amgen$35
- Stemline Therapeutics Inc.$30
- plus $70 from 3 others
Across 22 payments — averaging $22,639 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Puma Biotechnology, Inc.$269K
- Merck$229K
What the payments were for
- Consulting fees$5,96177%
- Food & beverage$7049%
- Education$120%
- Other$1,09814%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Taiho Oncology, Inc. | 4 | $4,259 |
| Novartis | 16 | $3,304 |
| Gilead | 3 | $41 |
| AstraZeneca | 2 | $36 |
| Amgen | 2 | $35 |
| Stemline Therapeutics Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $29 |
| Puma Biotechnology, Inc. | 1 | $21 |
| Foundation Medicine, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,776 in reported general payments places this provider in the 55th percentile of 379 medical oncology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 16 | $309 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Duarte
- Daneng LiDuarte$467K
- Howard WestDuarte$426K
- Christine LovlyDuarte$362K
- Marwan FakihDuarte$203K
- Erminia MassarelliDuarte$176K
- Ravi SalgiaDuarte$142K
- Tanya DorffDuarte$136K
- Karen ReckampDuarte$132K
- Cy SteinDuarte$122K
- Joseph ChaoDuarte$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.